Insider Trading & Ownership of Robert E. Gagnon

Location: Needham, MA
Summary: The estimated net worth of Robert E. Gagnon is at least $691K dollars as of 18 Dec 2025. Robert E. Gagnon is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $381K. Robert E. Gagnon is the Chief Financial Officer of Opus Genetics, Inc. and owns shares of Opus Genetics, Inc. (IRD) stock worth about $212K. Robert E. Gagnon is the Director of Bone Biologics Corp and owns shares of Bone Biologics Corp (BBLG) stock worth about $49.1K. Robert E. Gagnon is the Director of HARVARD BIOSCIENCE INC and owns shares of HARVARD BIOSCIENCE INC (HBIO) stock worth about $48.8K.
Signature: /s/ Daniel Calkins, Attorney in Fact
All Insider Reports: All Insider Reports

Notify me when Robert E. Gagnon files a new Insider Trading report.

Ownership of Robert E. Gagnon

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VSTM	Verastem, Inc.	Director	$381K	-$8.97K	-2.3%	16 Dec 2025
IRD	Opus Genetics, Inc.	Chief Financial Officer	$212K			02 Sep 2025
BBLG, BBLGW	Bone Biologics Corp	Director	$49.1K			04 Jun 2025
HBIO	HARVARD BIOSCIENCE INC	Director	$48.8K			16 Jul 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.